Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Jun 29, 2022 10:30pm

189 Views

Post# 34792625

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:AGM

Thanks ScienceFirst yes definitely 270 is the key as we've seen little change from 270 through to 450. Love to know what the percentage will be for the patient range 26 to 125, my opinion is it will be in the range we had guessed of 70% +. Too bad about the first 12 underdosing but it also demonstrated even a low dose can deliver CR.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario